Rebound of psoriasis after efalizumab discontinuation, despite being on high-dose cyclosporine.

Journal of drugs in dermatology : JDD

Volumn 6, Issue 9, 2007, Pages 941-944

  Maskatia, Zahida Khan ^a   Koo, John ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DERMATOLOGICAL AGENT; EFALIZUMAB; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; HUMAN; MALE; PATHOLOGY; PSORIASIS; RECURRENT DISEASE; REMISSION; TIME; TREATMENT WITHDRAWAL;

ADULT; ANTIBODIES, MONOCLONAL; CYCLOSPORINE; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PSORIASIS; RECURRENCE; REMISSION INDUCTION; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 38449113898     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)